ribavirin inhalation solution — Medica
Respiratory Virus Treatment, Excluding COVID-19
Initial criteria
- Patient is hospitalized
- Patient meets ONE of the following: solid organ transplant recipient; OR had a hematopoietic stem cell transplant; OR has cancer
- Medication is prescribed by or in consultation with a critical care specialist, transplant physician, oncologist, infectious diseases physician, or pulmonologist
Approval duration
1 month